SEARCH

SEARCH BY CITATION

References

  • 1
    Mackay IR, Taft LJ, Cowling DC. Lupoid hepatitis. Lancet 1956; 2: 13231326.
  • 2
    Storch W. Immunopathology and human autoimmunity in chronic active hepatitis. Scand J Gastroenterol 1988; 23: 513516.
  • 3
    Morizane T, Tsuchimoto K, Iino A, Matsumura S, Saito H, Satoh I, Kumagai N, et al. Two different murine monoclonal antibodies B2 and H2 which are specific for human hepatocytes (in Japanese with English abstract). Kanzou ( Acta Hepatologica Japonica) 1986; 27: 726735.
  • 4
    Saito H, Morizane T, Lino A, Tsuchimoto K, Hamada Y, Satoh I, Sawaguchi K, et al. Characterization of human liver-specific antigen 1 (HLSA 1) defined by the murine monoclonal antibody H2 (in Japanese with English abstract). Nippon Shoukakibyou Gakkai Zasshi (Jpn J Gastroenterol) 1987; 84: 675683.
  • 5
    MacFarlane IG, Heagrty JE, McSorley CG, McFarlane BM, Williams R. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 1984; 2: 954956.
  • 6
    McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoantibodies reacting with the hepatic asialo-glycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 1986; 3: 196205.
  • 7
    Hopf U, Meyer zum Buschenfelde KH, Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 1976; 294: 578582.
  • 8
    Lee WM, Shelton LL, Galbraith RM. Antibodies to hepatocyte membrane antigens in chronic liver disease: detection by immunofluorescence after Bouin's fixation. J Histochem Cytochem 1983; 31: 12461249.
  • 9
    Sheron N, Eddleston A. Autoimmune chronic active hepatitis. In: McLntyleN, et al., eds. Oxford textbook of clinical hepatology. New York: Oxford University Press, 1991: 758767.
  • 10
    Saito H, Morizane T, Watanabe T, Kagawa T, Miyaguchi S, Kumagai N, Tsuchiya M. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int J Cancer 1991; 48: 291296.
  • 11
    McDonell MW, Simon MN, Studier FW. Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels. J Mol Biol 1977; 110: 119125.
  • 12
    McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 10771083.
  • 13
    Alexander JJ, Bey EM, Geddes EW, Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 1976; 50: 21242128.
  • 14
    Watanabe T, Morizane T, Tsuchimoto K, Inagaki Y, Munakata Y, Nakamura T, Kumagai N, Tsuchiya M. Establishment of a human cell line (HCC-M) from a human hepatocellular carcinoma. Int J Cancer 1983; 32: 141146.
  • 15
    Saito H, Morizane T, Watanabe T, Kagawa T, Iwabuchi N, Kumagai N, Inagaki Y, et al. Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer 1989; 64: 10541060.
  • 16
    Chang RSM. Continuous subcultivation of epithelial-like cells from normal human tissues. Proc Soc Exp Biol Med 1954; 87: 440443.
  • 17
    Prasad D, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, Huebner K, et al. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc Natl Acad Sci U S A 1994; 91: 81078111.
  • 18
    Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 9981005.
  • 19
    Morizane T. Idiotype network and autoimmune hepatitis. In: NishiokaM, TodaG, ZeniyaM, eds. Autoimmune hepatitis. Amsterdam: Elsevier, 1994: 233250.
  • 20
    Hara S, Ishii E, Tanaka S, Hata J. A monoclonal antibody specifically reactive with Ewing's sarcoma. Br J Cancer 1989; 60: 875879.
  • 21
    Kaartinen M, Griffiths GM, Markham AF, Milstein C. mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature 1983; 304: 320324.
  • 22
    Huston JS, Levinson D, Mudgett-Huster M, Tai M-S, Novotny J, Margolies MN, Ridge RJ, et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 1988; 85: 58795883.
  • 23
    Whitlow M, Filpula D. Single-chain Fv proteins and their fusion proteins. Methods:A Companion to Methods in Enzymology 1991; 2: 97105.
  • 24
    Takkinen K, Laukkanen M-L, Sizmann D, Alfthan K, Immonen T, Vanne L, Kaartinen M, et al. An active single-chain antibody containing a cellular linker domain is secreted by Escherichia coli. Protein Eng 1991; 4: 837841.
  • 25
    Rasched I, Oberer E. Ff coliphages: Structural and functional relationship. Microbiol Rev 1986; 50: 401427.
  • 26
    Messing J. Cloning in M13 phage or how to use biology at its best. Gene 1991; 100: 312.
  • 27
    Meyer zum Buschenfelde KH, Kossling FK, Miescher PA. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol 1972; 11: 99108.
  • 28
    Ogawa M, Mori Y, Mori T, Ueda S, Yoshida H, Kato I, Iesato K, et al. Adoptive transfer of experimental autoimmune hepatitis in mice: cellular interaction between donor and recipient mice. Clin Exp Immunol 1988; 73: 276282.
  • 29
    Lohse AW, Manns M, Dienes HP, Meyer zum Buschenfelde KH, Cohen IR. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 1990; 11: 2430.
  • 30
    MacFarlane IG, Eddleston ALWF. Chronic active hepatitis. In: TargauF, ShanahauS, eds. Immunology and immunopathology of the liver and gastrointestinal tract. New York: Igaku-Shoin, 1989: 345351.
  • 31
    Kagawa T, Saito H, Morizane T, Tsuchimoto K, Inagaki Y, Sawaguchi K, Iwabuchi N, et al. Antibody-dependent cell-mediated cytotoxicity against cell lines generated by liver-specific idiotype-bearing antibody. J Gastroenterol 1995; 30: 201208.
  • 32
    Manns MP, Johnson EF, Giffin KJ, Tan EM, Sullivan KF. The major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome p450 dbl. J Clin Invest 1989; 83: 10661072.
  • 33
    Manns M, Kyriatsoulia A, Amelizad Z, Gerken G, Lohse A, Raske K, Buschenfelde KH. Relationship between the target antigen of liver-kidney microsomal (LKM) autoantibodies and rat isoenzymes of cytochrome P-450. J Clin Lab Anal 1988; 2: 245248.
  • 34
    Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde K-H. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; 1: 292294.